Trial Profile
Assessment of Phototoxicity Potential of Delafloxacin in Healthy Male and Female Subjects: a Phase 1 Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary) ; Lomefloxacin
- Indications Skin disorders
- Focus Adverse reactions
- Sponsors Melinta Therapeutics
- 29 Oct 2015 New trial record
- 14 Sep 2015 Results presented at Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.